Outcomes in Pediatric & Young Adult B-Cell Malignancies After Commercially

Updated 05/03/2024

Status Not yet recruiting

Clinical Trial Summary

To use a consistent and standardized platform to retrospectively and prospectively study children and young adults with B cell malignancies receiving Immunotherapy, blinatumomab and/or inotuzumab ozogamicin.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05865301
Study type	Observational
Source	Stanford University
Contact	Khanh Nguyen
Phone	(650) 721-2372
Email	khanhpn@stanford.edu
Status	Not yet recruiting
Phase
Start date	August 30, 2024
Completion date	August 30, 2024

See also
	Status	Clinical Trial	Phase
	Completed	`NCT00469729` - Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy	Phase 2/Phase 3
	Completed	`NCT03575325` - Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia	Phase 2
	Completed	`NCT03613727` - Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients	Phase 2
	Completed	`NCT02593123` - Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis	Phase 2
	Completed	`NCT00683046` - T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies	Phase 2
	Completed	`NCT01754857` - Bendamustine and Rituximab Induction Therapy and Maintenance Rituximab and Lenalidomide in Previously Untreated CLL/SLL	Phase 2
	Active, not recruiting	`NCT04472286` - Healthy Bones, Healthy Life: Habitual Physical Activity on Bone & Metabolic Health in Pediatric Cancer Survivors
	Terminated	`NCT01643603` - Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies	Phase 1
	Completed	`NCT02719821` - Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation	N/A
	Recruiting	`NCT00801580` - My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia	Phase 2
	Recruiting	`NCT05871008` - Integrated Actionable Aging Assessment for Cancer Patients Pilot	N/A
	Terminated	`NCT04155840` - Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma	Phase 2
	Suspended	`NCT02462265` - Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients	Phase 2
	Completed	`NCT02955043` - Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery	N/A
	Recruiting	`NCT05507827` - Safety of Myeloablative Conditioning, Orca-T, and Allogeneic, Donor-Derived CD19/CD22-CAR (Chimeric Antigen Receptor) T Cells in Adults With B-cell Acute Lymphoblastic Leukemia (ALL)	Phase 1